Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,52 USD | -1,20% | -3,62% | -4,38% |
22/03 | Denali Therapeutics dient Prospectus in voor bijkomend aanbod | MT |
28/02 | DENALI THERAPEUTICS INC. : B. Riley bevestigt koopadvies | ZM |
Vakgebied
Aantal werknemers: 445
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 108 | 100,0 % | 331 | 100,0 % | +204,74% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 108 | 100,0 % | 331 | 100,0 % | +204,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Schuth
FOU | Founder | 50 | 14-10-13 |
Ryan Watts
FOU | Founder | 48 | 14-10-13 |
Joe Lewcock
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Dana Andersen
CTO | Chief Tech/Sci/R&D Officer | - | 07-08-18 |
Carole Ho
CTO | Chief Tech/Sci/R&D Officer | 51 | 01-06-15 |
Steve Krognes
BRD | Director/Board Member | 56 | 01-10-15 |
Laura G. Hansen
IRC | Investor Relations Contact | - | - |
Katie Peng
PRN | Corporate Officer/Principal | - | 27-09-21 |
Erica Kratz
LAW | General Counsel | - | - |
Chris Walsh
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vicki Sato
CHM | Chairman | 75 | 01-04-15 |
Jay Flatley
BRD | Director/Board Member | 71 | 01-04-15 |
David Schenkein
BRD | Director/Board Member | 66 | 01-04-15 |
Founder | 64 | 14-10-13 | |
Jennifer Cook
BRD | Director/Board Member | 58 | 06-11-18 |
Peter Klein
BRD | Director/Board Member | 61 | 16-03-18 |
Erik Harris
BRD | Director/Board Member | 54 | 07-02-22 |
Steve Krognes
BRD | Director/Board Member | 56 | 01-10-15 |
Nancy Thornberry
BRD | Director/Board Member | 67 | 08-01-21 |
Ryan Watts
FOU | Founder | 48 | 14-10-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 139 160 239 | 122 610 849 ( 88,11 %) | 0 | 88,11 % |
Bedrijfsgegevens
Denali Therapeutics, Inc.
161 Oyster Point Boulevard
94080, San Francisco
+650-866-8548
http://www.denalitherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,38% | 2,96 mld. | |
+2,73% | 108 mld. | |
+9,59% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,29% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Denali Therapeutics Inc. - Nasdaq
- Onderneming Denali Therapeutics Inc.